Old Web
English
Sign In
Acemap
>
authorDetail
>
Erzsébet Szentkiralyi Szekely
Erzsébet Szentkiralyi Szekely
Lund University
Diffuse large B-cell lymphoma
Immunology
Population
Medicine
Confidence interval
4
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Impact on survival of addition of etoposide to primary chemotherapy in diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study
2017
Hematological Oncology
Tove Wästerlid
Linda Werner-Hartman
Erzsébet Szentkiralyi Szekely
Mats Jerkeman
Show All
Source
Cite
Save
Citations (10)
Season of diagnosis is associated with overall survival in patients with diffuse large B-cell lymphoma but not with Hodgkin's lymphoma - A population-based Swedish Lymphoma Register study.
2016
European Journal of Haematology
Erzsébet Szentkiralyi Szekely
Ola Lindén
Stefan Peterson
Mats Jerkeman
Show All
Source
Cite
Save
Citations (2)
Routine imaging for diffuse large B-cell lymphoma in first remission is not associated with better survival: A Danish-Swedish poulation-based study
2015
ICML | International Conference on Machine Learning
Tarec Christoffer El-Galaly
Lasse Hjort Jakobsen
Martin Hutchings
Peter de Nully Brown
Herman Nilsson-Ehle
Erzsébet Szentkiralyi Szekely
V Hjalmar
Karen Juul Mylam
Hans Erik Johnsen
Martin Bøgsted
Mats Jerkeman
Show All
Source
Cite
Save
Citations (0)
R-CHOEP-14 Is Associated with Superior Overall Survival Compared to R-CHOP-21 and R-CHOP-14 in Patients with DLBCL ≤70 Years – a Swedish Lymphoma Registry Population Based Study
2014
Blood
Tove Wästerlid
Erzsébet Szentkiralyi Szekely
Linda Werner-Hartman
Mats Jerkeman
Show All
Source
Cite
Save
Citations (1)
1